Addictions Neuroclinical Assessment (ANA)
Sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA)
About this trial
Last updated 2 years ago
Study ID
10000406
Status
Enrolling by invitation
Type
Observational
Placebo
No
Accepting
18+ Years
All
Trial Timing
Started 4 years ago
What is this trial about?
Background:
Alcohol use disorder (AUD) is a major public health problem. In the U.S., 16 to 18 million
adults have an AUD. Researchers want to test an assessment tool called the ANA. It uses
self-report and behavioral measures to assess 3 neuroscience domains of addiction. They hope
to better understand, manage, prevent, and treat AUD.
Objective:
To learn how people s brains function related to their drinking.
Eligibility:
People ages 18 years and older who have enrolled in NIAAA natural history study 14-AA-0181.
Design:
Participants will complete surveys and tasks on a computer. The surveys and tasks assess a
range of aspects of thinking and making decisions. The surveys and tasks also assess
behaviors and feelings about alcohol and other rewards, and negative emotions. Participants
will spend 90 minutes on the computer. Then they will take a break. In total, they will spend
4 blocks of time on the computer. Each block will last 90 minutes. They will take a break in
between each block of time. They can take more breaks if needed.
Outpatient participants and healthy volunteers will complete this study in 1 visit. It will
last about 6 hours. A second visit may be scheduled if needed. Outpatient participants will
take a breath alcohol test. If their test is positive, their visit may be rescheduled or they
may be withdrawn from the study.
Inpatient participants will complete this study over several days.
Data collected from participants in this study may be combined and analyzed with their data
from NIAAA study 14-AA-0181 and/or NIAAA imaging study 14-AA-0080.
What are the participation requirements?
Inclusion Criteria
1. Participants must be > 18 years of age
2. Participants must have enrolled in the NIAAA Screening Protocol (14-AA-0181).